The FDA has approved Gazyva (obinutuzumab) as an add-on treatment for adults with lupus nephritis, Genentech said.
Relief from lupus pain can be seen as a placeholder, not unlike that moment before a great discovery, writes columnist ...
ADI-001 led to reductions in disease activity for seven lupus patients in a clinical trial, with no serious side effects reported, data show.
Protecting your energy is crucial in life with chronic illness, says columnist Marisa Zeppieri, so be sure to avoid things that drain you.
What would you do if you were stuck in the grocery store parking lot, crippled by locked joints? Imagine your hands and wrists frozen after parking the car, with toes cramped, shifted apart, and bent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results